Results 211 to 220 of about 43,229 (277)

Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study. [PDF]

Front Med (Lausanne)
Wang Z, Wang X, Zhou L, Shi S, Hua Y, Feng Y.   +5 more
europepmc   +1 more source

Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D. [PDF]

Trop Med Infect Dis
Gherlan GS, Lazar SD, Culinescu A, Smadu D, Vatafu AR, Popescu CP, Florescu SA, Ceausu E, Calistru PI.   +8 more
europepmc   +1 more source

Pegylated Interferon Combined With Low-Dose Total Skin Electron Beam Therapy for Advanced Stage Mycosis Fungoides: Two Case Reports and Literature Review. [PDF]

Adv Radiat Oncol
Elsayad K, Stadler R, Eich HT.
europepmc   +1 more source

Image 1_A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24.tif

Nan Kong (6917111), Kaixia Wang (5585582), Yiling Wang (620129), Shike Lou (14786614), Luocheng Zhou (22474099), Tao Wang (12008), Zhili Tan (19196512), Lihong Qu (2102689)   +7 more
openalex   +1 more source

The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zhang X, Yang X, Tan L, Tian Y, Zhao Z, Ru S.   +5 more
europepmc   +1 more source

A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients. [PDF]

J Clin Microbiol
Luo M, Dong C, Liang X, Na R, Zhou B, Hou J, Jiang D-K.   +6 more
europepmc   +1 more source

Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis. [PDF]

Hepatol Int
Jiang S, Guo S, Huang Y, Yin Y, Feng J, Zhou H, Guo Q, Wang W, Xin H, Xie Q.   +9 more
europepmc   +1 more source

Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi. [PDF]

Euroasian J Hepatogastroenterol
Butt N, Usmani MT, Hussain R, Mughal S, Arisar FAQ.   +4 more
europepmc   +1 more source

A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study. [PDF]

Front Cell Infect Microbiol
Zhong W, Yan L, Zhu Y, Shi L, He Y, Chen T, Zheng J.   +6 more
europepmc   +1 more source